
Keywords: Aza, Azathioprine; AUC, Area under curve; HD, Haemodialysis; MMF, Mycophenolate mofetil; PD, Peritoneal dialysis; PRA, Panel reactive antibody; ROC, Receiver operating characteristic; RITS, Rituximab Induction Therapy Study; sCD30, Soluble CD30; TDS, Tacr